- Home
- PNBK vs PLX Comparison
PNBK vs PLX Comparison
Compare PNBK & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNBK
- PLX
- Stock Information
- Founded
- PNBK 1999
- PLX 1993
- Country
- PNBK United States
- PLX United States
- Employees
- PNBK N/A
- PLX N/A
- Industry
- PNBK Major Banks
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PNBK Finance
- PLX Health Care
- Exchange
- PNBK Nasdaq
- PLX Nasdaq
- Market Cap
- PNBK 146.4M
- PLX 127.4M
- IPO Year
- PNBK N/A
- PLX 1998
- Fundamental
- Price
- PNBK $1.43
- PLX $1.91
- Analyst Decision
- PNBK
- PLX Strong Buy
- Analyst Count
- PNBK 0
- PLX 1
- Target Price
- PNBK N/A
- PLX $15.00
- AVG Volume (30 Days)
- PNBK 255.6K
- PLX 705.4K
- Earning Date
- PNBK 08-14-2025
- PLX 11-13-2025
- Dividend Yield
- PNBK N/A
- PLX N/A
- EPS Growth
- PNBK N/A
- PLX N/A
- EPS
- PNBK N/A
- PLX 0.08
- Revenue
- PNBK $15,640,000.00
- PLX $61,948,000.00
- Revenue This Year
- PNBK N/A
- PLX $14.53
- Revenue Next Year
- PNBK N/A
- PLX $75.77
- P/E Ratio
- PNBK N/A
- PLX $24.60
- Revenue Growth
- PNBK N/A
- PLX 62.79
- 52 Week Low
- PNBK $0.90
- PLX $0.99
- 52 Week High
- PNBK $7.47
- PLX $3.10
- Technical
- Relative Strength Index (RSI)
- PNBK 42.87
- PLX 70.20
- Support Level
- PNBK $1.33
- PLX $1.52
- Resistance Level
- PNBK $1.51
- PLX $1.69
- Average True Range (ATR)
- PNBK 0.10
- PLX 0.08
- MACD
- PNBK -0.01
- PLX 0.03
- Stochastic Oscillator
- PNBK 32.26
- PLX 91.67
About PNBK Patriot National Bancorp Inc.
Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.